Radiotherapy and multimodality management of cholangiocarcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 1, 1999, Pages 121-126

  Urego, Marcella ^a   Flickinger, John C ^a,b   Carr, Brian I ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Biliary cancer; Chemotherapy; Cholangiocarcinoma; Radiotherapy

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0033010315     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00509-4     Document Type: Article

References (28)

1. Boris W.K., Yuman F., Leslie H.B. Proximal bile duct tumors. Surg Oncol Clin North Am. 1996;317-334.
2. Marcos A., Jenkins R. Cholangiocarcinoma. Surg Oncol Clin North Am. 1996;301-316.
3. Lotze MT, Flickinger JC, Carr BI. Hepatobiliary neoplasms. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 4th ed. 1993. p. 883-914.
4. Lowenfelds A.B., Norman J. Isoniazid and the bile duct cancer. JAMA. 240:1978;434.
5. Chen M.F., Jan Y.Y., Wang C.S., et al. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer. 64:1989;2226-2231.
6. Schilinkert R.T., Nagorney D.M., Van Heerden J.A., et al. Intrahepatic cholangiocarcinoma Clinical aspects, pathology and treatment . HPB Surg. 50:1992;101.
7. Alden M.E., Mohiuddin M. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer. Int J Radiat Oncol Biol Phys. 28:1994;945-951.
8. Buskirk S.J., Gunderson L.L., Schild S.E., et al. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg. 215:1992;125-131.
9. Flickinger J.C., Epstein A., Iwatzuki S., Carr B., Starzl T. Radiation therapy for primary carcinoma of the extrahepatic biliary system. Cancer. 68:1991;289-294.
10. Fritz P., Brambs H.J., Schraube P., et al. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas. Int J Radiat Oncol Biol Phys. 29:1994;855-861.
11. Grove M.K., Hermann R.E., Vogt D.P., Broughan T.A. Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg. 161:1991;454-458.
12. Hsue V., Wong C.S., Moore M., et al. A phase I study of combined radiation therapy with 5-fluorouracil and low dose folinic acid in patients with locally advanced pancreatic or biliary carcinoma. Int J Radiat Oncol Biol Phys. 34:1996;445-450.
13. Kamada T., Saitou H., Takamura A., Nojima T., Okushiba S.I. The role of radiotherapy in the management of extrahepatic bile duct cancer An analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy . Int J Radiat Oncol Biol Phys. 34:1996;767-774.
14. Montemaggi P., Morganti A.G., Dobelbower R.R. Jr, et al. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers Is it just for palliation? Radiology. 199:1996;861-866.
15. Tollenaar R.A., van de Velde C.J., Taat C.W., et al. External radiotherapy and extrahepatic bile duct cancer. Eur J Surg. 157:1991;587-589.
16. Tsujino K., Landry J.C., Smith R.G., et al. Definitive radiation therapy for extrahepatic bile duct carcinoma. Radiology. 196:1995;275-280.
17. Vauthey J.N., Blumgart L.H. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis. 14:1994;109-114.
18. Wolkov H.B., Graves G.M., Won M. Intraoperative radiation therapy of extrahepatic biliary carcinoma A report of RTOG-8506 . Am J Clin Oncol. 15:1992;323-327.
19. Yehuda Z., Jones D., Hoque A., et al. Phase II trial of intravenous fluorouracil and subcutaneous interferon alfa 2b for biliary tract cancer. J Clin Oncol. 14:1996;2311-2315.
20. Whittington R., Neuberg D., Tester W.J., et al. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma A phase I Eastern Cooperative Oncology Group Trial . J Clin Oncol. 13:1995;227-232.
21. Mogavero G.T., Jones B., Cameron J.L., et al. Gastric and duodenal obstruction in patients with cholangiocarcinoma in the porta hepatis Increased prevalence after radiation therapy . Am J Roent. 159:1992;1001-1003.
22. Pitt H.A., Nakeeb A., Abrams R.A., et al. Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival. Ann Surg. 221:1995;788-797.
23. Schoenthaler R., Castro J.R., Halberg F.E., Phillips T.L. Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons. Int J Radiat Oncol Biol Phys. 27:1993;75-82.
24. Kaplan E.L., Meier P. Non-parametric estimation and incomplete observations. J Am Stat Assoc. 53:1958;457-481.
25. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II analysis and examples . Br J Cancer. 35:1977;1-39.
26. Cox D.R. Regression models and life tables. J R Stat Soc B. 34:1972;187-220.
27. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 59:1987;2006-2010.
28. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 336:1985;980-987.